{"id":28490,"date":"2026-07-27T08:00:15","date_gmt":"2026-07-27T08:00:15","guid":{"rendered":"https:\/\/www.oxypharm.net\/?p=28490"},"modified":"2026-07-02T10:43:14","modified_gmt":"2026-07-02T10:43:14","slug":"candidozyma-auris-hospital-hygiene","status":"publish","type":"post","link":"https:\/\/www.oxypharm.net\/en\/candidozyma-auris-hospital-hygiene\/","title":{"rendered":"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen"},"content":{"rendered":"

[vc_row][vc_column][vc_single_image image=”28448″ img_size=”full” css=”” el_class=”full-width”][vc_column_text css=””]Candidozyma auris<\/strong> (formerly Candida auris) is an emerging yeast that is causing increasing concern in healthcare settings. First recorded in Japan in 2009, it is now responsible for outbreaks in many countries, including France, and is listed among the priority fungal pathogens identified by the WHO.<\/p>\n

 <\/p>\n

In a healthcare setting, the main challenge posed by Candidozyma auris<\/strong> lies in its ability to rapidly and persistently colonise the hospital environment. This is why the SF2H (French Society for Hospital Hygiene), the SFMM (French Society of Medical Mycology)<\/strong> and the Pasteur Institute place environmental bio-cleaning at the heart of their prevention measures, whilst synergistic approaches, such as steam and airborne surface disinfection (ASD), are attracting growing interest.[\/vc_column_text][vc_column_text css=””]<\/p>\n

Candidozyma auris: an emerging pathogen of particular concern<\/h3>\n

[\/vc_column_text][vc_column_text css=””]<\/p>\n

EPIDEMIOLOGY OF CANDIDOZYMA AURIS: A RAPID SPREAD IN FRANCE AND ABROAD<\/h4>\n

[\/vc_column_text][vc_row_inner content_placement=”middle”][vc_column_inner width=”1\/4″][vc_single_image image=”28455″ img_size=”FULL” css=””][\/vc_column_inner][vc_column_inner width=”3\/4″][vc_column_text css=””]Surveillance data show a rapid rise in Candidozyma auris, with its circulation now well documented in both the United States and Europe. In 2024, more than 6,000 infections were reported in the United States. In Europe, more than 1,300 cases had already been recorded by 2023.<\/p>\n

 <\/p>\n

In France, recent trends show a need for increased vigilance. The first French case was identified retrospectively in 2007. Since then, 89 cases have been recorded, 65 of which have been reported since 2023. In other words, nearly 73% of French cases have been reported over the last three years.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_column_text css=””]In 2025 alone, 22 clusters were identified, accounting for 37 cases.<\/strong><\/p>\n

The introduction of C. auris<\/strong> into France remains predominantly linked to patients repatriated for medical reasons or who have recently been hospitalised abroad.[\/vc_column_text][vc_column_text css=””]<\/p>\n

CLINICAL RISK IN COLONISED OR INFECTED PATIENTS<\/h4>\n

[\/vc_column_text][vc_column_text css=””]Candidozyma auris can colonise the skin for long periods without causing any symptoms. However, this colonisation can progress to an invasive infection. In colonised individuals, the risk of infection is estimated at 15%.<\/p>\n

 <\/p>\n

When the infection reaches the bloodstream, causing candidemia, the mortality rate is estimated at 30%.<\/p>\n

 <\/p>\n

Patient management can be complicated by variable susceptibility to antifungals depending on the strain and clade, which can limit the available treatment options or even lead to treatment dead-ends.[\/vc_column_text][vc_column_text css=””]<\/p>\n

Why is bio-cleaning central to the prevention of Candidozyma auris ?<\/h3>\n

[\/vc_column_text][vc_column_text css=””]<\/p>\n

A YEAST THAT TURNS THE HOSPITAL ENVIRONMENT INTO A RESERVOIR FOR TRANSMISSION<\/h4>\n

[\/vc_column_text][vc_column_text css=””]C. auris<\/strong> is characterised by its ability to persist for several weeks indoors. It adheres to numerous surfaces, such as skin, glass, plastic, steel and textiles.<\/p>\n

 <\/p>\n

This characteristic promotes prolonged skin colonisation in patients, as well as long-term contamination of their immediate environment. A vast number of surfaces therefore become potential reservoirs for in-hospital transmission.[\/vc_column_text][vc_column_text css=””]<\/p>\n

BIOFILMS AND MULTIPLE INFECTION HOTSPOTS: TWO REASONS TO BOLSTER BIO-CLEANING<\/h4>\n

[\/vc_column_text][vc_column_text css=””]C. auris<\/strong> can persist in free-floating form or as a biofilm. These biofilms promote the microorganism\u2019s adhesion and survival. They can also reduce its susceptibility to certain disinfectants.<\/p>\n

 <\/p>\n

What\u2019s more, environmental contamination by C. auris<\/strong> takes the form of multiple hotspots. This pathogen can simultaneously colonise numerous items in the patient\u2019s environment including beds, mattresses, bed rails, call bells, remote controls, shared equipment and door handles.<\/p>\n

 <\/p>\n

Its widespread distribution makes it extremely difficult to define the boundaries of contaminated areas. As a result, the detection of C. auris<\/strong> on a single surface often suggests more extensive contamination, potentially involving many others.<\/p>\n

 <\/p>\n

This environmental spread significantly increases the risk of cross-contamination.[\/vc_column_text][vc_column_text css=””]<\/p>\n

RECOMMENDATIONS FROM PROFESSIONAL BODIES<\/h4>\n

[\/vc_column_text][vc_row_inner content_placement=”middle”][vc_column_inner width=”2\/3″][vc_column_text css=””]According to the SF2H, the SFMM and the CPIAS (Centres for the Prevention of Healthcare-Associated Infections)<\/strong>, environmental disinfection is one of the essential measures for preventing the transmission of Candidozyma auris.<\/p>\n

[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_single_image image=”28476″ img_size=”FULL” css=””][\/vc_column_inner][\/vc_row_inner][vc_column_text css=””]It must be carried out at least once every 24 hours in the patient\u2019s room and on the patient\u2019s equipment, and ideally twice a day.<\/p>\n

 <\/p>\n

The recommendations emphasise areas most at risk: the immediate surroundings of the patient, but also surfaces frequently touched by healthcare staff, in particular door handles, medical equipment and shared devices.<\/p>\n

 <\/p>\n

Bio-cleaning must combine vigorous scrubbing, detergent action and effective disinfection. The aim is to remove organic matter, visible soiling and biofilms, and to reduce microbial contamination of surfaces. Treatment quality must be monitored by paramedical staff, in conjunction with the infection control team.<\/p>\n

 <\/p>\n

When a patient is discharged, double bio-cleaning is recommended, ideally carried out by two separate healthcare professionals.[\/vc_column_text][vc_column_text css=””]<\/p>\n

Why does Candidozyma auris present a major challenge for hospital hygiene?<\/h3>\n

[\/vc_column_text][vc_column_text css=””]According to the SF2H, the SFMM and the CPIAS (Centres for the Prevention of Healthcare-Associated Infections)<\/strong>, environmental disinfection is one of the essential measures for preventing the transmission of Candidozyma auris. It must be carried out at least once every 24 hours in the patient\u2019s room and on the patient\u2019s equipment, and ideally twice a day.[\/vc_column_text][vc_column_text css=””]<\/p>\n

Why does Candidozyma auris present a major challenge for hospital hygiene ?<\/h3>\n

[\/vc_column_text][vc_column_text css=””]<\/p>\n

VARIABLE SUSCEPTIBILITY TO CERTAIN DISINFECTANTS<\/h4>\n

[\/vc_column_text][vc_column_text css=””]Environmental control of Candidozyma auris<\/strong> is complicated by variable susceptibility to certain disinfectants, depending on the strain and clade. Current research raises questions regarding the efficacy of certain quaternary ammonium compounds. Biofilm formation may, in particular, contribute to reducing the susceptibility of certain strains to disinfectants. Although C. auris does not produce spores, sporicidal-level disinfectants are recommended, particularly chlorinated derivatives, hydrogen peroxide and peracetic acid.<\/strong>[\/vc_column_text][vc_column_text css=””]<\/p>\n

STEAM: AN EFFECTIVE ADDITIONAL APPROACH<\/h4>\n

[\/vc_column_text][vc_column_text css=””]In the context of environmental control of C. auris, the SF2H and the SFMM<\/strong> are calling for proof of the effectiveness of steam. This is now available, thanks to tests carried out in accordance with the NF T 72-110<\/strong> standard, providing evidence of steam\u2019s effectiveness against C. auris.<\/p>\n

 <\/p>\n

Steam addresses several practical concerns for hygiene teams. It provides effective solutions against C<\/strong>. auris that are suited to on-site constraints and safe for both patients and healthcare professionals, whilst also limiting the use of chemicals to minimise environmental impact.[\/vc_column_text][vc_column_text css=””]<\/p>\n

AIRBORNE SURFACE DISINFECTION : A RESPONSE TO WIDESPREAD OUTBREAKS OF C. AURIS<\/h4>\n

[\/vc_column_text][vc_row_inner content_placement=”middle”][vc_column_inner width=”1\/2″][vc_single_image image=”28462″ img_size=”FULL” css=””][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text css=””]C. auris<\/strong> can contaminate numerous surfaces in the patient\u2019s environment, leading to widespread outbreaks. This ubiquitous presence complicates the thorough treatment of all at-risk areas.<\/p>\n

This is precisely the benefit of airborne surface disinfection. This method automatically disperses a disinfectant (often hydrogen peroxide) throughout the entire dimensions of a room, reaching all exposed surfaces including the most inaccessible areas.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_column_text css=””]Regulated and certified by the NF EN 17272 standard<\/strong>, airborne surface disinfection processes have demonstrated fungicidal and sporicidal efficacy against particularly resistant microorganisms.<\/p>\n

 <\/p>\n

Its ability to reach widespread hotspots and its broad-spectrum efficacy explain the major benefit of airborne surface disinfection (ASD) in controlling environmental contamination associated with C. auris.<\/strong><\/p>\n

 <\/p>\n

The SF2H and the SFMM<\/strong> therefore recommend terminal disinfection of surfaces via airborne application, particularly in the event of an uncontrolled outbreak.[\/vc_column_text][vc_column_text css=””]<\/p>\n

Conclusion<\/h3>\n

[\/vc_column_text][vc_row_inner content_placement=”middle”][vc_column_inner width=”1\/4″][vc_single_image image=”28469″ img_size=”FULL” css=””][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text css=””]The main challenge presented by Candidozyma auris<\/strong> is not only its resistance to certain antifungal treatments, but its ability to become established long-term in the healthcare environment. In response to this challenge, professional recommendations suggest the same approach: to bolster bio-cleaning, combine several synergistic levels of action such as steam and high-pressure steam cleaning (ASD)<\/strong>, and rigorously document the effectiveness of the processes used.[\/vc_column_text][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_single_image image=”28441″ img_size=”Full” css=””][\/vc_column_inner][\/vc_row_inner][vc_column_text css=””]To address current health and environmental challenges, Oxy\u2019Pharm<\/strong> embodies an integrated and eco-biological approach to hospital hygiene<\/strong>, combining Sanivap for high-pressure steam bio-cleaning, and Nocotech for airborne surface bio-disinfection.<\/strong>[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Learn how bio-cleaning, steam and airborne surface disinfection help prevent the spread of Candidozyma auris.<\/p>\n","protected":false},"author":3,"featured_media":28450,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[55],"tags":[290,349,291,235,87,120,227,201,215,187,351],"class_list":["post-28490","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles-en","tag-bio-nettoyage-en","tag-c-auris-en","tag-dsva-en","tag-nf-t-72-110-desinfection-vapeur-en","tag-nocotech-en","tag-oxypharm-en","tag-sanivap-en","tag-sante","tag-sf2h-en","tag-sf2h","tag-sfm-en"],"acf":[],"yoast_head":"\nCandidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen - Oxy'Pharm<\/title>\n<meta name=\"description\" content=\"Candidozyma auris: prevention strategies in hospital hygiene, from bio-cleaning to airborne surface disinfection.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen - Oxy'Pharm\" \/>\n<meta property=\"og:description\" content=\"Candidozyma auris: prevention strategies in hospital hygiene, from bio-cleaning to airborne surface disinfection.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/\" \/>\n<meta property=\"og:site_name\" content=\"Oxy'Pharm\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100065087790394\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-27T08:00:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png\" \/>\n\t<meta property=\"og:image:width\" content=\"660\" \/>\n\t<meta property=\"og:image:height\" content=\"364\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"marketing\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@OxyPharm\" \/>\n<meta name=\"twitter:site\" content=\"@OxyPharm\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"marketing\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/\"},\"author\":{\"name\":\"marketing\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8\"},\"headline\":\"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen\",\"datePublished\":\"2026-07-27T08:00:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/\"},\"wordCount\":1548,\"publisher\":{\"@id\":\"https:\/\/www.oxypharm.net\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png\",\"keywords\":[\"bio-nettoyage\",\"C.Auris\",\"DSVA\",\"NF T 72-110 d\u00e9sinfection vapeur\",\"nocotech\",\"Oxy'Pharm\",\"sanivap\",\"Sant\u00e9\",\"SF2H\",\"SF2H\",\"SFM\"],\"articleSection\":[\"Articles\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/\",\"url\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/\",\"name\":\"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen - Oxy'Pharm\",\"isPartOf\":{\"@id\":\"https:\/\/www.oxypharm.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png\",\"datePublished\":\"2026-07-27T08:00:15+00:00\",\"description\":\"Candidozyma auris: prevention strategies in hospital hygiene, from bio-cleaning to airborne surface disinfection.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#primaryimage\",\"url\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png\",\"contentUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png\",\"width\":660,\"height\":364},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.oxypharm.net\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.oxypharm.net\/#website\",\"url\":\"https:\/\/www.oxypharm.net\/\",\"name\":\"Oxy'Pharm\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.oxypharm.net\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.oxypharm.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.oxypharm.net\/#organization\",\"name\":\"Oxy'pharm\",\"alternateName\":\"Oxypharm\",\"url\":\"https:\/\/www.oxypharm.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg\",\"contentUrl\":\"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg\",\"width\":500,\"height\":500,\"caption\":\"Oxy'pharm\"},\"image\":{\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/profile.php?id=100065087790394\",\"https:\/\/x.com\/OxyPharm\",\"https:\/\/www.instagram.com\/oxy_pharm\/\",\"https:\/\/www.linkedin.com\/company\/oxy-pharm\/\",\"https:\/\/www.youtube.com\/channel\/UCwTjwWFZWcMdPPlvkTuiurw\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8\",\"name\":\"marketing\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen - Oxy'Pharm","description":"Candidozyma auris: prevention strategies in hospital hygiene, from bio-cleaning to airborne surface disinfection.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/","og_locale":"en_US","og_type":"article","og_title":"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen - Oxy'Pharm","og_description":"Candidozyma auris: prevention strategies in hospital hygiene, from bio-cleaning to airborne surface disinfection.","og_url":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/","og_site_name":"Oxy'Pharm","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100065087790394","article_published_time":"2026-07-27T08:00:15+00:00","og_image":[{"width":660,"height":364,"url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png","type":"image\/png"}],"author":"marketing","twitter_card":"summary_large_image","twitter_creator":"@OxyPharm","twitter_site":"@OxyPharm","twitter_misc":{"Written by":"marketing","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#article","isPartOf":{"@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/"},"author":{"name":"marketing","@id":"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8"},"headline":"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen","datePublished":"2026-07-27T08:00:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/"},"wordCount":1548,"publisher":{"@id":"https:\/\/www.oxypharm.net\/#organization"},"image":{"@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png","keywords":["bio-nettoyage","C.Auris","DSVA","NF T 72-110 d\u00e9sinfection vapeur","nocotech","Oxy'Pharm","sanivap","Sant\u00e9","SF2H","SF2H","SFM"],"articleSection":["Articles"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/","url":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/","name":"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen - Oxy'Pharm","isPartOf":{"@id":"https:\/\/www.oxypharm.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#primaryimage"},"image":{"@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#primaryimage"},"thumbnailUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png","datePublished":"2026-07-27T08:00:15+00:00","description":"Candidozyma auris: prevention strategies in hospital hygiene, from bio-cleaning to airborne surface disinfection.","breadcrumb":{"@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#primaryimage","url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png","contentUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2026\/07\/vignette-article-Candidozyma.png","width":660,"height":364},{"@type":"BreadcrumbList","@id":"https:\/\/www.oxypharm.net\/candidozyma-auris-hygiene-hospitaliere\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.oxypharm.net\/en\/"},{"@type":"ListItem","position":2,"name":"Candidozyma auris and hospital hygiene: strategies for tackling this emerging pathogen"}]},{"@type":"WebSite","@id":"https:\/\/www.oxypharm.net\/#website","url":"https:\/\/www.oxypharm.net\/","name":"Oxy'Pharm","description":"","publisher":{"@id":"https:\/\/www.oxypharm.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.oxypharm.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.oxypharm.net\/#organization","name":"Oxy'pharm","alternateName":"Oxypharm","url":"https:\/\/www.oxypharm.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/","url":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg","contentUrl":"https:\/\/www.oxypharm.net\/wp-content\/uploads\/2023\/06\/Logo-Medtradex-Oxypharm.jpg","width":500,"height":500,"caption":"Oxy'pharm"},"image":{"@id":"https:\/\/www.oxypharm.net\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100065087790394","https:\/\/x.com\/OxyPharm","https:\/\/www.instagram.com\/oxy_pharm\/","https:\/\/www.linkedin.com\/company\/oxy-pharm\/","https:\/\/www.youtube.com\/channel\/UCwTjwWFZWcMdPPlvkTuiurw"]},{"@type":"Person","@id":"https:\/\/www.oxypharm.net\/#\/schema\/person\/4e54abf170588a0853a460e68ac97dc8","name":"marketing"}]}},"_links":{"self":[{"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/posts\/28490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/comments?post=28490"}],"version-history":[{"count":3,"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/posts\/28490\/revisions"}],"predecessor-version":[{"id":28503,"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/posts\/28490\/revisions\/28503"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/media\/28450"}],"wp:attachment":[{"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/media?parent=28490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/categories?post=28490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.oxypharm.net\/en\/wp-json\/wp\/v2\/tags?post=28490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}